Ischemic disease of lower extremity
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. patients who underwent percutaneous endovascular intervention; 2. ASA grade II -III; 3. patients aged 63-85 years old, sex is not limited; 4. patients have fully understandthe nature of the study, voluntary participation in this experiment andsigned informed consent.
Exclusion criteria
Exclusion criteria: 1. known to the study of the drug ingredients allergies andallergic constitution; 2. puncture site skin ulcers; 3. coronary heart disease; bronchial asthma; severe hypertension; heart andlung disease andliver andkidney function is not complete; serious blood system dysfunction; 4. obesity (BMI>30); 5. The history of nervous system disease, drug addiction andalcoholism; 6. Clinical trials of other drugs in the past 4 weeks; 7. compliance is poor, can not be completed by the research program; 8. for any reason, the researchers believe that there is any situation that is not suitable for inclusion.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Resting Visual Analogue Scale;Motor Visual Analogue Scale;Knee flexion angle; | — |